Skip to main content
AIDS (London, England)
Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV.
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents.
Outcomes of immunomodulatory and biologic therapy in people living with HIV.
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events.
Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events.
Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study.
Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches.
MicroRNAs: novel tools to block gut inflammation in HIV?
